Journal
MEDICAL ONCOLOGY
Volume 39, Issue 3, Pages -Publisher
HUMANA PRESS INC
DOI: 10.1007/s12032-021-01633-4
Keywords
Oral cancer; Ras/Raf/MEK/ERK; PI3K/AKT/mTOR; Therapeutic; Biomarker
Categories
Ask authors/readers for more resources
The rapid growth of oral cancer is a significant concern, especially in developing countries. Early detection and development of novel therapies can improve patient survival. This review explores the key pathways in oral cancer and analyzes the association between protein expression level, genetic mutation, and therapeutic intervention.
The rapid growth of oral cancer is a significant concern, especially in developing countries due to the advanced lifestyle and 5-year survival despite advanced multimodality of cancer care. The poor modality might be due to the detection of disease in the advanced stage. Early detection and development of novel therapies can improve oral cancer patient survival. The PI3K/AKT/mTOR and RAS-RAF-MEK-ERK are very extensively exploited pathways in oral cancer. These pathways are very critical in the progression of tumorigenesis in oral cancer. This review focuses on the association of Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways in terms of protein expression level, genetic mutation, and therapeutic intervention in oral cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available